Apr 09, 2012, 04.38 PM | Source: CNBC-TV18
SBI chief Pratip Chaudhuri attributed increased government borrowing to be the cause for the rise in bond yields. He called for a cut in CRR by the RBI to ease the crunch in funds.
Bond yields have seen a spike of late although they have cooled slightly today. But the spike has alarmed the banking sector. SBI ’s Pratip Chaudhuri attributes increased government borrowing for the yield curve going up. The solution, he explains, is a CRR cut by the central bank.
“The yield curve going up means that the government is borrowing too much and the banking system is not able to provide as much funding. So the only way to ease the supply crunch is cut CRR,” SBI’s Pratip Chaudhuri told CNBC-TV18.
SBI stock price
On February 05, 2016, State Bank of India closed at Rs 168.20, up Rs 5.15, or 3.16 percent. The 52-week high of the share was Rs 315.80 and the 52-week low was Rs 160.80.
The company's trailing 12-month (TTM) EPS was at Rs 18.69 per share as per the quarter ended September 2015. The stock's price-to-earnings (P/E) ratio was 9. The latest book value of the company is Rs 168.75 per share. At current value, the price-to-book value of the company is 1.00.
Conditions ripe to start NPL de-stressing cycle: Sanjay Nayar
Sanjay Nayar, CEO at KKR India says, it is crucial
Avoid metals, PSBs safe bet as 2-3 year investment: UTI MF
In an interview with CNBC-TV18, Swati Kulkarni, Ex
Get in SBI at around Rs 150-155; may test Rs 250: Vijay Chopra
According to Vijay Chopra of enochventures.com, on
Govt to infuse about Rs 5,000 cr in PSU banks this quarter
"As committed, banks will get fund infusion in the
SBIâ€™s gross NPAs to rise by Rs 35K cr in H2FY16: Morgan Stanley
Brokerage firm Morgan Stanley thinks of this short
SBI new home loan offers 3-5 yrs interest moratorium to NewGen
With the "FlexiPay Home Loan", the bank seeks to b
Women can win over subconscious discrimination: SBI Chairman
SBI Chairman Arundhati Bhattacharya said women hav
SBI Life to consider IPO post capital infusion by JV partner
"Hike in capital infusion to the extent of 10 perc